From Seattle Life Sciences 2029 Photo Gallery:

friendulrichryo2029—

Stephen Friend took time to network afterwards with Roger Ulrich, the chief development officer of Calistoga Pharmaceuticals and Ryo Kubota, the chairman and CEO of Acucela.

Underwriters and Partners

Xconomy Insight

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

From Our Editors · Special Report
2019 Biopharma Outlook – Facing an Uncertain Future
Key indicators & expert insight from industry leaders
Xconomy

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy Boston

Life Sciences IPOs Target Collective Raise of More Than $600M This Week

Flagship Adds Fertility-Focused Ohana Biosciences to Biotech Family

ArcherDX Raises $55M to Help Physicians Pick Best Cancer Therapies

Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal

Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira

Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits

Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%

CEOs of Women’s Health Companies Fight to Open Investment Floodgates

Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers

A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns

Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing

AI Can Unlock Health Data's Potential, But Access Is Still Difficult

ArcherDX Raises $55M to Help Physicians Pick Best Cancer Therapies

Healthcare AI Tech is Here, Now We Must Learn to Manage the Data

Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy

Xcelerating Life Sciences San Diego

From Seattle Life Sciences 2029 Photo Gallery:

Underwriters and Partners

Robert Langer reveals secrets to early-stage biotech success

2019 Biopharma Outlook – Facing an Uncertain Future

How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook

Xconomy on Demand

We offer a number of ways to subscribe for free!